Given the intricate interplay between these systems, this study will systematically elucidate the bidirectional relationships between tau and the neuronal cytoskeletal network, aiming to unravel AD-related cytoskeletal dysregulation mechanisms and identify novel therapeutic targets to mitigate tau-driven cognitive decline. The gene discussed is MAPT; the disease is Mental deterioration.